1. Home
  2. RDWR vs EVO Comparison

RDWR vs EVO Comparison

Compare RDWR & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$29.90

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.80

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDWR
EVO
Founded
1996
1993
Country
Israel
Germany
Employees
N/A
4553
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
994.5M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
RDWR
EVO
Price
$29.90
$2.80
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$32.50
$7.00
AVG Volume (30 Days)
209.4K
29.9K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.65
$1.37
Revenue Next Year
$8.62
$10.05
P/E Ratio
$59.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.68
$2.31
52 Week High
$31.92
$4.42

Technical Indicators

Market Signals
Indicator
RDWR
EVO
Relative Strength Index (RSI) 60.62 51.49
Support Level $23.45 $2.60
Resistance Level $31.92 $3.82
Average True Range (ATR) 1.28 0.07
MACD 0.07 0.01
Stochastic Oscillator 97.86 88.89

Price Performance

Historical Comparison
RDWR
EVO

About RDWR Radware Ltd.

Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: